The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Professor Sandra Lindstedt, is a senior consultant in cardiothoracic surgery specializing in heart and lung transplantation, with a long-standing interest in lung transplantation-related research, post-transplant complications and lung regeneration. Professor Lindstedt did her post-doc in Professor Steens laboratory in the early 2000s and was a part of the team who did the first clinical trial in the world using ex vivo lung perfusion on marginal donor lungs in 2005 at Lund University Hospital, Sweden.
Professor Lindstedt currently holds the position as the chair of the surgical lung transplant program at Lund University Hospital and the position as the vice-chair of the Scandiatransplant Heart and Lung Group (SHLG) and the position as the Chair of the European Cell Therapy and Organ Regeneration Section (ECTORS) board within The European Society for Organ Transplantation (ESOT).
Since 2020 Professor Lindstedt serves as a section editor for the Journal of Heart and Lung Transplantation (JHLT). Professor Lindstedt is the principal investigator for a translational research group. The Lindstedt group has created ex vivo human models and in vivo and ex vivo porcine models of lung injuries and a pig lung transplantation survival model. The Lindstedt group are currently working to develop therapies within these models. Interested in pursuing this research, as well as other settings of lung regeneration following lung injury such as primary graft dysfunction, with the aim to treat damaged donor lungs and to increase the number of lungs suitable for transplantation but also to reduce complications after lung transplantation by increasing the tolerability of the new organ and bring this research towards clinical applications.
